Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of ECI301 in Combination With Radiation in Patients With Advanced or Metastatic Cancer

NCT01441115 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01441115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01441115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of ECI301 in Combination With Radiation in Patients With Advanced or Metastatic Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Terminated
Start date
September 6, 2011
Completion date
April 24, 2013
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, metastasis, neoplasm, neoplasm metastasis, radiation oncology